563 related articles for article (PubMed ID: 14504866)
1. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
[TBL] [Abstract][Full Text] [Related]
2. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
Pepas LP; Arif-Adib M; Kadir RA
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493
[TBL] [Abstract][Full Text] [Related]
3. Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage.
Nohira T; Osakabe Y; Suda S; Takahashi C; Tanaka A; Ikeda K; Ikeda T; Okabe K
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):623-30. PubMed ID: 18840167
[TBL] [Abstract][Full Text] [Related]
4. Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa.
Gidiri M; Noble W; Rafique Z; Patil K; Lindow SW
J Obstet Gynaecol; 2004 Nov; 24(8):925-6. PubMed ID: 16147656
[No Abstract] [Full Text] [Related]
5. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW
Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726
[TBL] [Abstract][Full Text] [Related]
6. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
Franchini M; Franchi M; Bergamini V; Salvagno GL; Montagnana M; Lippi G
Semin Thromb Hemost; 2008 Feb; 34(1):104-12. PubMed ID: 18393147
[TBL] [Abstract][Full Text] [Related]
7. Massive obstetric hemorrhage due to placenta previa/accreta with prior cesarean section.
Manyonda IT; Varma TR
Int J Gynaecol Obstet; 1991 Feb; 34(2):183-6. PubMed ID: 1671376
[TBL] [Abstract][Full Text] [Related]
8. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
[TBL] [Abstract][Full Text] [Related]
10. Major obstetric hemorrhage.
Mercier FJ; Van de Velde M
Anesthesiol Clin; 2008 Mar; 26(1):53-66, vi. PubMed ID: 18319179
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
[TBL] [Abstract][Full Text] [Related]
12. [Successful application of recombinant activated factor VII in a patient with HELLP syndrome and disseminated intravascular coagulation].
Ilić-Mostić T; Argirović R; Sparić R; Ljubić A; Bozanović T; Jeremić K; Tomanović-Koković J; Kadija S
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():253-8. PubMed ID: 19562879
[TBL] [Abstract][Full Text] [Related]
13. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
14. [Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
Pekhlivanov B; Milchev N; Abrashev B
Akush Ginekol (Sofiia); 2003; 42(6):7-9. PubMed ID: 15067806
[TBL] [Abstract][Full Text] [Related]
15. Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage*.
Ojala K; Perälä J; Kariniemi J; Ranta P; Raudaskoski T; Tekay A
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1075-80. PubMed ID: 16232175
[TBL] [Abstract][Full Text] [Related]
16. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage.
Franchini M; Lippi G; Franchi M
BJOG; 2007 Jan; 114(1):8-15. PubMed ID: 17233855
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study.
Barillari G; Frigo MG; Casarotto M; Farnia A; Massè B; Wetzl R; Bianchin A; Rabi A; Malacarne P; Pasca S; Bigotto E;
Thromb Res; 2009 Dec; 124(6):e41-7. PubMed ID: 19783283
[TBL] [Abstract][Full Text] [Related]
18. [Post-partum hemorrhage: new therapeutic options].
Franchini M
Recenti Prog Med; 2007 Jan; 98(1):7-11. PubMed ID: 17345873
[TBL] [Abstract][Full Text] [Related]
19. [Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy].
Sobieszczyk S; Breborowicz GH; Markwitz W; Mallinger S; Adamski D; Kruszyński Z
Ginekol Pol; 2002 Mar; 73(3):230-3. PubMed ID: 12092258
[TBL] [Abstract][Full Text] [Related]
20. Transfusion therapy in postpartum hemorrhage.
Padmanabhan A; Schwartz J; Spitalnik SL
Semin Perinatol; 2009 Apr; 33(2):124-7. PubMed ID: 19324242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
